| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |